Idh-mutant Diffuse Glioma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-09
Clinical Trial Update: Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
Clinical trial update: vorasidenib is being studied for CNS WHO Grade 2 IDH-mutant diffuse glioma. The study is currently recruiting.